SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $162,000 | -13.8% | 5,886 | +3.5% | 0.01% | -14.3% |
Q2 2019 | $188,000 | -5.5% | 5,686 | 0.0% | 0.01% | -12.5% |
Q1 2019 | $199,000 | +5.3% | 5,686 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $189,000 | -33.9% | 5,686 | 0.0% | 0.01% | -20.0% |
Q3 2018 | $286,000 | +1.8% | 5,686 | +21.3% | 0.01% | -9.1% |
Q2 2018 | $281,000 | +30.7% | 4,686 | 0.0% | 0.01% | +22.2% |
Q1 2018 | $215,000 | +20.1% | 4,686 | +4.5% | 0.01% | +12.5% |
Q4 2017 | $179,000 | +25.2% | 4,486 | +25.1% | 0.01% | +14.3% |
Q3 2017 | $143,000 | +8.3% | 3,586 | +17.1% | 0.01% | 0.0% |
Q2 2017 | $132,000 | +164.0% | 3,062 | +91.4% | 0.01% | +133.3% |
Q1 2017 | $50,000 | +42.9% | 1,600 | +14.3% | 0.00% | +50.0% |
Q4 2016 | $35,000 | 0.0% | 1,400 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $35,000 | -39.7% | 1,400 | -35.7% | 0.00% | +100.0% |
Q2 2016 | $58,000 | -58.6% | 2,178 | -76.2% | 0.00% | -50.0% |
Q1 2016 | $140,000 | +9.4% | 9,144 | -3.7% | 0.00% | 0.0% |
Q4 2015 | $128,000 | – | 9,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |